AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, M. D.
Right arrow Articles by Reynolds III, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M. D.
Right arrow Articles by Reynolds III, C. F.
Am J Geriatr Psychiatry 10:592-598, October 2002
© 2002 American Association for Geriatric Psychiatry


Regular Article

Effect of Cerebrovascular Risk Factors on Depression Treatment Outcome in Later Life

Mark D. Miller, M.D., Eric J. Lenze, M.D., Mary Amanda Dew, Ph.D., Ellen Whyte, M.D., Elizabeth Weber, M.S.N., Amy E. Begley, M.A., and Charles F. Reynolds III, M.D.

Received November 30, 2000; revised March 9, 2001; accepted May 16, 2001. From the Intervention Research Center in Late-Life Mood Disorders, Department of Psychiatry, University of Pittsburgh School of Medicine. Address correspondence to Dr. Miller, 100 North Bellefield, Pittsburgh, PA 15213. e-mail: millermd{at}msx.upmc.edu

OBJECTIVE: The vascular depression hypothesis posits that depression can arise in late life from cerebrovascular damage and that depression arising this way has a different clinical presentation and is more chronic and treatment-resistant than early-onset depression. This study tested the relationship of cerebrovascular risk factors (CVRF) to clinical presentation and treatment outcome in 156 subjects enrolled in a long-term maintenance treatment study of late-life recurrent major depression. METHODS: CVRF scores were generated with the Probability of Stroke Risk Profile. Subjects with the highest one-third of scores were designated High CVRF, and their baseline clinical presentation and treatment outcomes were compared with the remaining subjects. RESULTS: In the High-CVRF group, a greater proportion of subjects had first-onset depression after age 60. However, high CVRF score, late onset of depression, and their interaction had no effect on time-to-remission, need for adjunctive medication, or increased risk for recurrence during 3-year follow-up. Furthermore, high CVRF score and late onset of depression did not predict the associated clinical features of vascular depression, such as psychomotor retardation and lack of insight, previously described in the literature. CONCLUSION: Optimism about the outcome of late-life depression treatment should not be diminished by the presence of high cerebrovascular risk.

Key Words: Depression • Cerebrovascular Factors • Risk Factors




This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
H. Variend and Y. V. Gopal
Late-onset depression: issues affecting clinical care
Advan. Psychiatr. Treat., March 1, 2008; 14(2): 152 - 158.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. Salzman
A 60-Year-Old Woman Who Has Felt Sad for Much of Her Life
JAMA, January 18, 2006; 295(3): 318 - 323.
[Full Text] [PDF]


Home page
AJGPHome page
H. R. Bogner, M. S. Cary, M. L. Bruce, C. F. Reynolds III, B. Mulsant, T. T. Have, G. S. Alexopoulos, and The PROSPECT Group
The Role of Medical Comorbidity in Outcome of Major Depression in Primary Care: The PROSPECT Study
Am J Geriatr Psychiatry, October 1, 2005; 13(10): 861 - 868.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
D. V. Iosifescu, N. Clementi-Craven, R. Fraguas, G. I. Papakostas, T. Petersen, J. E. Alpert, A. A. Nierenberg, and M. Fava
Cardiovascular Risk Factors May Moderate Pharmacological Treatment Effects in Major Depressive Disorder
Psychosom Med, September 1, 2005; 67(5): 703 - 706.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
H. C. Kales, D. F. Maixner, and A. M. Mellow
Cerebrovascular Disease and Late-Life Depression
Am J Geriatr Psychiatry, February 1, 2005; 13(2): 88 - 98.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. P. Devanand, N. Juszczak, M. S. Nobler, N. Turret, L. Fitzsimons, H. A. Sackeim, and S. P. Roose
An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder
J Geriatr Psychiatry Neurol, December 1, 2004; 17(4): 219 - 224.
[Abstract] [PDF]


Home page
AJGPHome page
B. T. Mast, S. Neufeld, S. E. MacNeill, and P. A. Lichtenberg
Longitudinal Support for the Relationship Between Vascular Risk Factors and Late-Life Depressive Symptoms
Am J Geriatr Psychiatry, February 1, 2004; 12(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
B. S. Meyers
Treatment and Course of Geriatric Depression: Questions Raised by an Evolving Clinical Science
Am J Geriatr Psychiatry, October 1, 2002; 10(5): 497 - 502.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2002 American Association for Geriatric Psychiatry